The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


RotaTeq



Merck Sharp & Dohme BV,EU/1/06/348/01

Main Information

Trade NameRotaTeq
Active SubstancesRotavirus vaccine, live, pentavalent gi
Rotavirus vaccine, live, pentavalent g2
Rotavirus vaccine, live, pentavalent g3
Rotavirus vaccine, live, pentavalent g4
Rotavirus vaccine, live, pentavalent p1
Dosage FormOral solution
Licence HolderMerck Sharp & Dohme BV,
Licence NumberEU/1/06/348/01

Group Information

ATC CodeJ07BH Rota virus diarrhea vaccines
J07BH02 rota virus, pentavalent, live, reassorted

Status

License statusAuthorised
Licence Issued27/06/2006
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back